Toggle navigation
About
Abstract
Editorial Board
Publication Schedule
Subscription & Newsletter
Contact
Issue
3-2
Table of Contents
Editors Selection
Glaucoma Dialogue
Glaucoma Opinion
Abstracts
Abstracts
Abstracted Journals
Classification List
Index of Authors
Search
Home
Abstracts
Classification
Classification #11.5.2
advertisement
11.5.2 Topical
(10)
Showing records 1 to 10
Display all abstracts in classification
11.5.2 Topical
Search within classification 11.5.2 Topical
6364
Changes in intraocular pressure associated with topical dorzolamide and oral methazolamide in glaucomatous dogs
Gelatt KN; MacKay EO
Veterinary Ophthalmology
2001; 4: 61-67
6397
Ocular hemodynamics and visual field in glaucoma treated with dorzolamide
Bernd AS; Pillunat LE; Boehm AG; Schmidt KG; Richard G
Ophthalmologe
2001; 98: 451-455
6440
Effect of topical dorzolamide hydrochloride on neovascular glaucoma
Hagiwara Y; Kimura Y; Miura F; Ito K; Otsubo A; Hagiwara N; Uehara H; Koike T; Kishi S
Japanese Journal of Clinical Ophthalmology
2001; 55: 1171-1174
6466
Efficacy of brimonidine 0.2% and dorzolamide 2% as adjunctive therapy to beta-blockers in adult patients with glaucoma or ocular hypertension
Simmons ST
Clinical Therapeutics
2001; 23: 604-619
6475
Correlation between intraocular pressure peaks in the diurnal tension curve and in the water-drinking provocative test: a study in primary open-angle glaucoma patients using timolol and dorzolamide
Medeiros FA; Leite CA; Susanna R Jr
Revista Brasileira de Oftalmologia
2001; 60: 418-423
6476
Intraindividual comparison of the effects of a fixed dorzolamide-timolol combination and latanoprost on intraocular pressure after small incision cataract surgery
Rainer G; Menapace R; Findl O; Petternel V; Kiss B; Georgopoulos M
Journal of Cataract and Refractive Surgery
2001; 27: 706-710
6497
Comparison of the additive intraocular pressure-lowering effect of latanoprost and dorzolamide when added to timolol in patients with open-angle glaucoma or ocular hypertension: a randomized, open-label, multicenter study in Greece
Petounis A; Mylopoulos N; Kandarakis A; Andreanos D; Dimitrakoulias N
Journal of Glaucoma
2001; 10: 316-324
6507
Comparison of topical brinzolamide 1% and dorzolamide 2% eye drops given twice daily in addition to timolol 0.5% in patients with primary open-angle glaucoma or ocular hypertension
Michaud JE; Friren B
American Journal of Ophthalmology
2001; 132: 235-243
6508
Carbonic anhydrase inhibitors: 4-sulfamoyl-benzenecarboxamides and 4-chloro-3-sulfamoyl-benzenecarboxamides with strong topical antiglaucoma properties
Mincione F; Starnotti M; Menabuoni L; Scozzafava A; Casini A; Supuran CT
Bioorganic and Medicinal Chemistry Letters
2001; 11: 1787-1791
6509
Comparisons of intraocular-pressure-lowering efficacy and side effects of 2% dorzolamide and 1% brinzolamide
Seong GJ; Lee SC; Lee JH; Chu YK; Hong YJ
Ophthalmologica
2001; 215: 188-191
Issue
3-2
Table of Contents
Editor's Selection
Change Issue
24-1 (2024)
23-4 (2023)
23-3 (2023)
23-2 (2023)
23-1 (2022)
22-4 (2022)
22-3 (2022)
22-2 (2021)
22-1 (2021)
21-4 (2021)
21-3 (2021)
21-2 (2021)
21-1 (2020)
20-4 (2020)
20-3 (2020)
20-2 (2019)
20-1 (2019)
19-4 (2019)
19-3 (2018)
19-2 (2018)
19-1 (2018)
18-4 (2017)
18-3 (2017)
18-2 (2017)
18-1 (2017)
17-4 (2016)
17-3 (2016)
17-2 (2016)
17-1 (2016)
16-4 (2015)
16-3 (2015)
16-2 (2015)
16-1 (2014)
15-4 (2014)
15-3 (2014)
15-2 (2013)
15-1 (2013)
14-4 (2013)
14-3 (2013)
14-2 (2013)
14-1 (2012)
13-4 (2012)
13-3 (2011)
13-2 (2011)
13-1 (2011)
12-4 (2011)
12-3 (2010)
12-2 (2010)
12-1 (2010)
11-4 (2010)
11-3 (2009)
11-2 (2009)
11-1 (2009)
10-4 (2009)
10-3 (2008)
10-2 (2008)
10-1 (2008)
9-4 (2008)
9-3 (2007)
9-2 (2007)
9-1 (2007)
8-4 (2007)
8-3 (2006)
8-2 (2006)
8-1 (2006)
7-3 (2006)
7-2 (2005)
7-1 (2005)
6-3 (2005)
6-2 (2004)
6-1 (2004)
5-3 (2004)
5-2 (2003)
5-1 (2003)
4-3 (2003)
4-2 (2002)
4-1 (2002)
3-3 (2002)
3-2 (2001)
3-1 (2001)
2-3 (2001)
2-2 (2000)
2-1 (2000)
1-3 (2000)
1-2 (1999)
1-1 (1999)
advertisement